CN111303035A - Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid - Google Patents

Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid Download PDF

Info

Publication number
CN111303035A
CN111303035A CN202010192683.0A CN202010192683A CN111303035A CN 111303035 A CN111303035 A CN 111303035A CN 202010192683 A CN202010192683 A CN 202010192683A CN 111303035 A CN111303035 A CN 111303035A
Authority
CN
China
Prior art keywords
methyl
pyrazole
difluoromethyl
carboxylic acid
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010192683.0A
Other languages
Chinese (zh)
Inventor
陈红
於万里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xuzhou Shengyuan Chemical Co ltd
Original Assignee
Xuzhou Shengyuan Chemical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xuzhou Shengyuan Chemical Co ltd filed Critical Xuzhou Shengyuan Chemical Co ltd
Priority to CN202010192683.0A priority Critical patent/CN111303035A/en
Publication of CN111303035A publication Critical patent/CN111303035A/en
Priority to CN202110278569.4A priority patent/CN112745265B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/141Feedstock

Abstract

The invention discloses a preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid, belonging to the technical field of organic synthesis. N-methyl-3-aminopyrazole is used as a raw material, reacts with bromine/iodine to substitute pyrazole 4 position, is diazotized and coupled with potassium difluoromethyl trifluoroborate to obtain 4-bromo-3- (difluoromethyl) -1-methyl-1H-pyrazole, is subjected to Grignard exchange by isopropyl magnesium chloride and the like, and reacts with carbon dioxide to obtain the 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid. The method is simple and convenient to operate, the total yield of the three steps is up to 64%, the product purity can reach more than 99.5%, the condition that isomers exist in the traditional process is avoided, and the method has a potential process amplification prospect.

Description

Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid
Technical Field
The invention relates to a preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid, belonging to the technical field of organic synthesis.
Background
3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid, english name: 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid, CAS: 176969-34-9. The 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid is an important medical and fine chemical intermediate, can be used for synthesizing various bactericides and pesticides, and particularly is a key intermediate for synthesizing novel amides bactericides such as fluopyram, bixafen and isopyrazam.
At present, the compound has more and more application values, the synthesis reports of the compound are more, and hydrazine or methylhydrazine is mostly used for cyclization, hydrolysis or oxidation and the like in the synthesis method. However, isomers are inevitably produced during the cyclization, and a great deal of effort is required for subsequent purification.
It is therefore necessary to develop more synthetic routes to avoid the isomers of the above products, with relative ease of operation, to meet the ever-increasing market demand.
Disclosure of Invention
In order to overcome the technical defects, the invention provides a preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid. N-methyl-3-aminopyrazole is used as a raw material, reacts with bromine/iodine to substitute pyrazole 4-position, is diazotized and coupled with potassium difluoromethyl trifluoroborate to obtain 4-bromo-3- (difluoromethyl) -1-methyl-1H-pyrazole, is subjected to Grignard exchange by isopropyl magnesium chloride, and reacts with carbon dioxide to obtain 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid. The method is simple and convenient to operate, the total yield of the three steps is up to 64%, the product purity can reach more than 99.5%, the condition that isomers exist in the traditional process is avoided, and the method has a potential process amplification prospect.
A method for preparing 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid, comprising the steps of:
the first step is as follows: dissolving N-methyl-3-aminopyrazole in water, and reacting with halogen to obtain 4-halogen-1-methyl-1H-pyrazole-3-amine;
the second step is that: reacting 4-halo-1-methyl-1H-pyrazole-3-amine with a sodium nitrite aqueous solution to obtain diazonium salt, and then reacting with potassium difluoromethyl trifluoroborate in the presence of cuprous oxide to obtain 4-halo-3- (difluoromethyl) -1-methyl-1H-pyrazole;
the third step: exchanging 4-halogen-3- (difluoromethyl) -1-methyl-1H-pyrazole by adopting a Grignard reagent, then cooling, reacting with carbon dioxide, quenching and recrystallizing to obtain the 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid.
Further, in the above technical solution, in the first step, the halogen is selected from bromine and iodine. When iodine is adopted, hydrogen peroxide is added for reaction.
Further, in the above technical solution, the molar ratio of N-methyl-3-aminopyrazole to halogen in the first step is 1: 0.5-1.05. Wherein, the iodine simple substance is needed to be approximately 0.5 equivalent, and the bromine is used for approximately equivalent reaction.
Further, in the above technical scheme, the molar ratio of the addition of the oxidized imino ketone and the addition of the 4-halogen-1-methyl-1H-pyrazol-3-amine in the second step is 0.05-0.10: 1.
furthermore, in the technical scheme, the molar ratio of the 4-halogen-1-methyl-1H-pyrazole-3-amine, the potassium difluoromethyl trifluoroborate and the sodium nitrite in the second step is 1:0.98-1.3: 2.0-2.5.
Further, in the above technical solution, in the third step, the grignard reagent is selected from isopropyl magnesium chloride, isopropyl magnesium chloride-lithium chloride or sec-butyl magnesium chloride-lithium chloride.
Further, in the above technical scheme, in the third step, the reaction with carbon dioxide is performed by introducing carbon dioxide gas or a saturated solution of carbon dioxide under the condition of a catalytic amount of DBU. The addition of DBU can reduce the consumption of carbon dioxide, accelerate the reaction speed and enhance the process stability.
Further, in the technical scheme, the molar ratio of the 4-halogen-3- (difluoromethyl) -1-methyl-1H-pyrazole, the Grignard reagent and the carbon dioxide in the third step is 1:1.01-1.15: 1-2.5.
Further, in the above technical solution, when the crystallization is performed in the third step, the solvent is selected from a mixture of an alcohol solvent and water used for the crystallization in the third step. The alcohol solvent is methanol, ethanol or isopropanol.
Further, in the above-mentioned embodiment, it is preferable that the crystallization in the third step is performed using 40% (v/v) ethanol aqueous solution.
Advantageous effects of the invention
The method takes N-methyl-3-aminopyrazole as a raw material, and comprises three steps of halogenation, diazo coupling, Grignard exchange/carbon dioxide and the like in sequence, and the product is finally purified after recrystallization. The method is simple and convenient to operate, the total reaction yield is up to 64%, the purity of the obtained product can reach more than 99.5%, and a new process approach is provided for the synthesis of the compounds.
DETAILED DESCRIPTION OF EMBODIMENT (S) OF INVENTION
The invention is further illustrated by the following specific examples. These examples are to be construed as merely illustrative and not limitative of the remainder of the disclosure in any way whatsoever. After reading the description of the invention, one skilled in the art can make various changes and modifications to the invention, and such equivalent changes and modifications also fall into the scope of the invention defined by the claims.
Example 1
Figure BDA0002416479720000041
97.1g (1mol,1.0eq) of N-methyl-3-aminopyrazole and 800mL of water and 500mL of ethanol are put into a three-port reaction bottle, 129.5g (0.51mol,0.51eq) of iodine is added in portions at the temperature of 15-25 ℃, and 72.9g (0.6mol,0.6eq) of 28% hydrogen peroxide is added dropwise at the temperature of 15-25 ℃. Heating to 30-35 ℃, reacting for 6 hours, taking a sample with GC raw material less than 1%, cooling to 10 ℃, adding 80mL of saturated sodium thiosulfate aqueous solution, stirring for 5-6 hours, distilling ethanol under reduced pressure, separating out a large amount of yellow-brown solid, filtering to obtain 207.6g of 4-iodine-1-methyl-1H-pyrazole-3-amine, wherein GC content is 95.6%, and yield is 93.1%.1HNMR(400MHz,CDCl3):7.40(s,1H),5.81(s,2H),3.80(s,3H).
Figure BDA0002416479720000042
4-iodine-1-methyl-1H-pyrazole-3-amine (100g,0.45mol) and 6mol/L hydrochloric acid aqueous solution are put into a reaction bottle, the pH value is regulated to be less than 1, the temperature is reduced to minus 5 ℃, 78.1g of 40 percent sodium nitrite aqueous solution is slowly dripped, the reaction is carried out for 1 hour at minus 5 to 5 ℃ after the dripping is finished, and the mixture is transferred into a dropping funnel under the protection of nitrogen.
Under the protection of nitrogen, adding 73.3g (470.8mmol,1.05eq) of potassium difluoromethyl trifluoroborate, 4.5g (31.4mmol,0.07eq) of cuprous oxide and 500mL of tetrahydrofuran into a reaction bottle, cooling to 0 ℃, starting to dropwise add the prepared diazonium salt solution, slowly heating to 35-50 ℃, sampling HPLC raw materials, cooling to 0-10 ℃, adding saturated sodium carbonate aqueous solution for quenching, extracting by ethyl acetate, washing an organic phase by water, concentrating, adding n-heptane for pulping, filtering to obtain 98.7g of 4-iodine-3- (difluoromethyl) -1-methyl-1H-pyrazole, and carrying out HPLC: 98.7% and yield 85.3%.1HNMR(400MHz,CDCl3):7.80(s,1H),6.02(s,1H),3.95(s,3H).
Figure BDA0002416479720000051
Under the protection of nitrogen, 95g (0.368mol,1eq) of 4-iodo-3-difluoromethyl-1-methylpyrazole and 500mL of tetrahydrofuran were put into a reaction flask, stirred uniformly, and then cooled to-5 ℃. 202mL of i-PrMgCl (2.0M,1.1eq) tetrahydrofuran solution was slowly added dropwise, and the mixture was stirred for 2 hours while maintaining the temperature after the addition of the solution, thereby obtaining a Grignard exchange solution. Sampling quenching GC detects that the raw material is less than 0.5 percent. 500mL of a tetrahydrofuran solution which is prepared in advance and contains 5.6g (0.037mol,0.1eq) of DBU and 21.6g (0.49mol,1.25eq) of carbon dioxide at-25 ℃ is added dropwise, the temperature is slowly increased to 0 ℃, the mixture is stirred for 5 hours at the temperature, the temperature is reduced to-10 ℃, 4mol/L hydrochloric acid is added for quenching, aqueous phase ethyl acetate is used for extraction, an organic phase is washed by water, an enriched organic phase is concentrated to a non-flowing liquid, the ethanol is replaced and then distilled to be dry again, and finally, 330mL of 40% (v/v) ethanol aqueous solution is added for recrystallization to obtain 53.9g of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid, the GC purity is 99.5%, and the yield is 83.2%.1HNMR(400MHz,DMSO-d6):12.71(s,1H),8.33(s,1H),7.19(t,1H),3.89(s,3H)。
Example 2:
Figure BDA0002416479720000061
adding 97.1g (1mol,1eq) of 1, 3-dimethylpyrazole and 700mL of ethanol into a reaction bottle, slowly dropwise adding 158.4g (0.99mol,0.99eq) of bromine at 0-5 ℃ under stirring, dropwise adding for reaction at 0-15 ℃ for 1 hour, sampling GC raw materials, reducing the temperature to 10 ℃, adding 500mL of water, dropwise adding 30% sodium hydroxide aqueous solution for quenching reaction, adjusting the pH to 9-10, adding 80mL of saturated sodium thiosulfate aqueous solution, concentrating an organic phase under reduced pressure, removing ethanol, reducing the temperature to 15-20 ℃, pulping for 3 hours, and filtering to obtain 157.4g of 4-bromo-1-methyl-1H-pyrazol-3-amine, wherein the GC yield is 89.4%.1HNMR(400MHz,CDCl3):7.41(s,1H),5.90(s,2H),3.82(s,3H).
Figure BDA0002416479720000062
Under the protection of nitrogen, 4-bromine-1-methyl-1H-pyrazole-3 is put into a reaction bottle100g (568.1mmol) of amine and 6mol/L aqueous hydrochloric acid, pH adjusted<1, cooling to-5 ℃, slowly dropwise adding 87.8g of 45% sodium nitrite aqueous solution, and reacting for 1 hour at-5-5 ℃ after dropwise adding. Adding 89.7g (568.1mmol,1.0eq) of potassium difluoromethyl trifluoroborate, 4.1g (28.4mmol,0.05eq) of cuprous oxide and 500mL of acetonitrile into another reaction bottle under the protection of nitrogen, cooling to 0 ℃, dropwise adding the prepared diazonium salt solution, slowly heating to 35-50 ℃, sampling HPLC raw materials, cooling to 0-10 ℃, adding saturated sodium carbonate aqueous solution for quenching, extracting by ethyl acetate, washing an organic phase by water, concentrating, distilling under reduced pressure to obtain 105.7g of 4-bromo-3- (difluoromethyl) -1-methyl-1H-pyrazole, and carrying out HPLC: 98.5% and a yield of 88.2%.1HNMR(400MHz,CDCl3):7.93(s,1H),6.05(s,1H),3.95(s,3H).
Figure BDA0002416479720000071
Under the protection of nitrogen, 95g (0.368mol,1eq) of 4-iodo-3-difluoromethyl-1-methylpyrazole and 500mL of 2-methyltetrahydrofuran were put into a reaction flask, stirred uniformly, and then cooled to-5 ℃. 311mL of a 2-methyltetrahydrofuran solution of i-PrMgCl-LiCl (1.3M,1.1eq) was slowly added dropwise, and the mixture was stirred for 2 hours while maintaining the temperature, thereby obtaining a Grignard exchange solution. Sampling quenching GC detects that the raw material is less than 0.5 percent. 500mL of a pre-prepared 2-methyltetrahydrofuran solution containing 5.6g (0.037mol,0.1eq) of DBU5 and 21.6g (0.49mol,1.25eq) of carbon dioxide at-25 ℃ is added dropwise, the temperature is slowly raised to 0 ℃, the mixture is stirred for 5 hours at the temperature, the temperature is reduced to-10 ℃, 4mol/L hydrochloric acid is added for quenching, the water phase is extracted by ethyl acetate, the organic phase is washed by water, the organic phase is enriched and concentrated to a non-flowing liquid, the ethanol is replaced and distilled again to be dry, and finally, 340mL of 40% (v/v) ethanol aqueous solution is added for recrystallization to obtain 54.8g of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid, the GC purity is 99.7%, and the yield is 84.6%.1HNMR(400MHz,DMSO-d6):12.71(s,1H),8.33(s,1H),7.19(t,1H),3.89(s,3H)。
Example 3:
Figure BDA0002416479720000072
adding 97.1g (1mol,1eq) of 1, 3-dimethylpyrazole and 700mL of ethanol into a reaction bottle, slowly dropwise adding 158.4g (0.99mol,0.99eq) of bromine at 0-5 ℃ under stirring, dropwise adding for reaction at 0-15 ℃ for 1 hour, sampling GC raw materials, reducing the temperature to 10 ℃, adding 500mL of water, dropwise adding 30% sodium hydroxide aqueous solution for quenching reaction, adjusting the pH to 9-10, adding 80mL of saturated sodium thiosulfate aqueous solution, concentrating an organic phase under reduced pressure, removing ethanol, reducing the temperature to 15-20 ℃, pulping for 3 hours, and filtering to obtain 157.4g of 4-bromo-1-methyl-1H-pyrazol-3-amine, wherein the GC yield is 89.4%.1HNMR(400MHz,CDCl3):7.41(s,1H),5.90(s,2H),3.82(s,3H).
Figure BDA0002416479720000081
Under the protection of nitrogen, 100g (568.1mmol) of 4-bromo-1-methyl-1H-pyrazol-3-amine and 6mol/L of hydrochloric acid aqueous solution are put into a reaction bottle, and the pH value is adjusted<1, cooling to-5 ℃, slowly dropwise adding 87.8g of 45% sodium nitrite aqueous solution, and reacting for 1 hour at-5-5 ℃ after dropwise adding. Adding 89.7g (568.1mmol,1.0eq) of potassium difluoromethyl trifluoroborate, 4.1g (28.4mmol,0.05eq) of cuprous oxide and 500mL of acetonitrile into another reaction bottle under the protection of nitrogen, cooling to 0 ℃, dropwise adding the prepared diazonium salt solution, slowly heating to 35-50 ℃, sampling HPLC raw materials, cooling to 0-10 ℃, adding saturated sodium carbonate aqueous solution for quenching, extracting by ethyl acetate, washing an organic phase by water, concentrating, distilling under reduced pressure to obtain 105.7g of 4-bromo-3- (difluoromethyl) -1-methyl-1H-pyrazole, and carrying out HPLC: 98.5% and a yield of 88.2%.1HNMR(400MHz,CDCl3):7.93(s,1H),6.05(s,1H),3.95(s,3H).
Figure BDA0002416479720000082
Under the protection of nitrogen, 95g (0.368mol,1eq) of 4-iodo-3-difluoromethyl-1-methylpyrazole and 500mL of tetrahydrofuran were put into a reaction flask, stirred uniformly, and then cooled to-5 ℃. S-BuMgCl-LiCl (1.2M,1.1eq) solution in tetrahydrofuran 337mL is slowly added dropwise, and stirring is carried out for 2 hours while maintaining the temperature after droppingAnd obtaining the Grignard exchange solution. Sampling quenching GC detects that the raw material is less than 0.5 percent. 500mL of a pre-prepared 2-methyltetrahydrofuran solution containing 5.6g (0.037mol,0.1eq) of DBU and 21.6g (0.49mol,1.25eq) of carbon dioxide at-25 ℃ is added dropwise, the temperature is slowly raised to 0 ℃, the mixture is stirred for 5 hours at the temperature, the temperature is reduced to-10 ℃, 4M/L hydrochloric acid is added for quenching, the water phase is extracted by ethyl acetate, the organic phase is washed by water, the organic phase is enriched and concentrated to a non-flowing liquid, the ethanol is replaced and distilled again to be dry, and finally, 320mL of 40% (v/v) ethanol aqueous solution is added for recrystallization to obtain 54.5g of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid, the GC purity is 99.6%, and the yield is 84.1%.1HNMR(400MHz,DMSO-d6):12.71(s,1H),8.33(s,1H),7.19(t,1H),3.89(s,3H)。
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be able to cover the technical solutions and the inventive concepts of the present invention within the technical scope of the present invention.

Claims (10)

1. A method for preparing 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid, which is characterized by comprising the following steps:
the first step is as follows: dissolving N-methyl-3-aminopyrazole in water, and reacting with halogen to obtain 4-halogen-1-methyl-1H-pyrazole-3-amine;
the second step is that: reacting 4-halo-1-methyl-1H-pyrazole-3-amine with a sodium nitrite aqueous solution to obtain diazonium salt, and then reacting with potassium difluoromethyl trifluoroborate in the presence of cuprous oxide to obtain 4-halo-3- (difluoromethyl) -1-methyl-1H-pyrazole;
the third step: exchanging 4-halogen-3- (difluoromethyl) -1-methyl-1H-pyrazole by adopting a Grignard reagent, then cooling, reacting with carbon dioxide, quenching and recrystallizing to obtain the 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid.
2. The process for the preparation of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid according to claim 1, characterized in that: in the first step, the halogen is selected from bromine and iodine elementary substance, wherein when the iodine elementary substance is adopted, hydrogen peroxide is added for reaction.
3. The process for the preparation of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid according to claim 1, characterized in that: in the first step, the molar ratio of the N-methyl-3-aminopyrazole to the halogen is 1: 0.5-1.05; wherein, the iodine simple substance adopts nearly 0.5 equivalent, and the bromine is adopted for nearly equivalent reaction.
4. The process for the preparation of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid according to claim 1, characterized in that: in the second step, the molar ratio of the addition of the oxidized imino ketone to the 4-halo-1-methyl-1H-pyrazol-3-amine is 0.05-0.10: 1.
5. the process for the preparation of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid according to claim 1, characterized in that: in the second step, the molar ratio of the 4-halogen-1-methyl-1H-pyrazole-3-amine, the potassium difluoromethyl trifluoroborate and the sodium nitrite is 1:0.98-1.3: 2.0-2.5.
6. The process for the preparation of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid according to claim 1, characterized in that: in the third step, the grignard reagent is selected from isopropyl magnesium chloride, isopropyl magnesium chloride-lithium chloride or sec-butyl magnesium chloride-lithium chloride.
7. The process for the preparation of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid according to claim 1, characterized in that: in the third step, the reaction with carbon dioxide is carried out by introducing carbon dioxide gas or carbon dioxide saturated solution and under the condition of catalytic amount of DBU.
8. The process for the preparation of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid according to claim 1, characterized in that: in the third step, the molar ratio of the 4-halo-3- (difluoromethyl) -1-methyl-1H-pyrazole, the Grignard reagent and the carbon dioxide is 1:1.01-1.15: 1-2.5.
9. The process for the preparation of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid according to any of claims 1 to 8, characterized in that: in the third step, a mixture of an alcohol solvent and water is used for crystallization.
10. The process for the preparation of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid according to claim 9, wherein: in the third step, 40% ethanol water solution is adopted for recrystallization.
CN202010192683.0A 2020-03-18 2020-03-18 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid Pending CN111303035A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202010192683.0A CN111303035A (en) 2020-03-18 2020-03-18 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid
CN202110278569.4A CN112745265B (en) 2020-03-18 2021-03-13 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010192683.0A CN111303035A (en) 2020-03-18 2020-03-18 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid

Publications (1)

Publication Number Publication Date
CN111303035A true CN111303035A (en) 2020-06-19

Family

ID=71151399

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202010192683.0A Pending CN111303035A (en) 2020-03-18 2020-03-18 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid
CN202110278569.4A Active CN112745265B (en) 2020-03-18 2021-03-13 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202110278569.4A Active CN112745265B (en) 2020-03-18 2021-03-13 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid

Country Status (1)

Country Link
CN (2) CN111303035A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112745265A (en) * 2020-03-18 2021-05-04 徐州圣元化工有限公司 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1033806C (en) * 1991-07-19 1997-01-15 道伊兰科公司 N-pyrazolyl-1,2,4-triazolo[1,5-c] pyrimidine-2-sulfonamide herbicides
CN101679282A (en) * 2007-06-01 2010-03-24 巴斯夫欧洲公司 Method for the production of N-substituted (3-dihalomethyl-1-methyl-pyrazole-4-yl) carboxamides
CN101687806A (en) * 2007-06-27 2010-03-31 先正达参股股份有限公司 Process for the production of pyrazoles
CN109970650A (en) * 2019-05-17 2019-07-05 南开大学 Pyrazole phenyl formamide analog derivative and its preparation method and application
CN110022875A (en) * 2016-07-11 2019-07-16 莱福斯希医药公司 Therapeutic inhibiting compound
WO2019142053A2 (en) * 2018-01-17 2019-07-25 Lifesci Pharmaceuticals, Inc. Therapeutic inhibitory compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111303035A (en) * 2020-03-18 2020-06-19 徐州圣元化工有限公司 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1033806C (en) * 1991-07-19 1997-01-15 道伊兰科公司 N-pyrazolyl-1,2,4-triazolo[1,5-c] pyrimidine-2-sulfonamide herbicides
CN101679282A (en) * 2007-06-01 2010-03-24 巴斯夫欧洲公司 Method for the production of N-substituted (3-dihalomethyl-1-methyl-pyrazole-4-yl) carboxamides
CN101687806A (en) * 2007-06-27 2010-03-31 先正达参股股份有限公司 Process for the production of pyrazoles
CN110022875A (en) * 2016-07-11 2019-07-16 莱福斯希医药公司 Therapeutic inhibiting compound
WO2019142053A2 (en) * 2018-01-17 2019-07-25 Lifesci Pharmaceuticals, Inc. Therapeutic inhibitory compounds
CN109970650A (en) * 2019-05-17 2019-07-05 南开大学 Pyrazole phenyl formamide analog derivative and its preparation method and application

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ETIENNE SCHMITT,等: "A Major Advance in the Synthesis of Fluoroalkyl Pyrazoles: Tuneable Regioselectivity and Broad Substitution Patterns", 《CHEM. EUR. J.》 *
JUN-LIANG ZENG,等: "Direct Regioselective [3 + 2] Cycloaddition Reactions of Masked Difluorodiazoethane with Electron-Deficient Alkynes and Alkenes:Synthesis of Difluoromethyl-Substituted Pyrazoles", 《ORG. LETT.》 *
MASAKAZU ATOBE ,等: "SAR-based optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as highly potent EP1 receptor antagonists", 《BIOORG. MED. CHEM. LETT.》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112745265A (en) * 2020-03-18 2021-05-04 徐州圣元化工有限公司 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid
CN112745265B (en) * 2020-03-18 2022-07-12 徐州圣元化工有限公司 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid

Also Published As

Publication number Publication date
CN112745265A (en) 2021-05-04
CN112745265B (en) 2022-07-12

Similar Documents

Publication Publication Date Title
CA2521695C (en) Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt
CN101440100B (en) Novel process for synthesizing cyclopropylboronic acid
CN111362874B (en) Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid
CN111303035A (en) Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid
WO2022228535A1 (en) Preparation method for nicotine and intermediate thereof
CN111559967B (en) Synthesis method of 4-amino-2-hydroxy-3-isopropoxybenzoic acid
CN111233768B (en) Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid ethyl ester
JPS62252740A (en) Intermediate for manufacturing insecticide
JPS6241578B2 (en)
CN107721941B (en) Preparation method of 3-amino-5-methyl isoxazole
CN113548982A (en) Preparation method of 4-cyano-2-fluorobenzyl alcohol
JP5448572B2 (en) Acetyl compound, method for producing the acetyl compound, and method for producing a naphthol compound using the acetyl compound
CN108794396B (en) Oxidation method of 4-oxo-2, 3-dihydroquinoline compound
CN111533656A (en) Synthesis method of tert-butyl 4-methoxy-3-oxobutyrate
CN112830895B (en) Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid
US9284249B2 (en) Method for extracting asymmetric β-diketone compound from β-diketone compound
CN112125864B (en) Synthesis method of 1,1 &#39;-diamino-5, 5&#39; -bitetrazole
CN107344916B (en) Prepare the intermediate and its preparation method and use of 7- halogen -2- oxoheptanoate
CN112552222B (en) Preparation method of 2- (2- (tert-butoxycarbonyl) -2-azaspiro [3.4] octane-5-yl) acetic acid
JP4065576B2 (en) Process for producing 2,6-di-tert-alkylcyclohexanols
CN115536643A (en) Preparation method of key intermediate of isavuconazole medicine
CN114380835A (en) Preparation method of 7- (3, 4-dimethoxyphenyl) -2-pyrazolo [1,5-A ] pyrimidine carboxylic acid
CN115925545A (en) Method for synthesizing DL-mandelic acid by one-pot method
JP2512958B2 (en) 1-biphenylylethanol derivative and process for producing the same
CN117776882A (en) Preparation method of 1, 3-dicarbonyl compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200619

WD01 Invention patent application deemed withdrawn after publication